$HIPH - Announces Development of Prototype Aerosol

New Post Public Reply Private Reply Replies (0) Message Board
stockstein
152
$HIPH - Announces Development of Prototype Aerosol Sanitizer Machine Using Proprietary Hydro-Nano Water

*Link below to Globe/Yahoo Recent News!

GlobeNewswireApril 22, 2020
The Device is Currently in the Developmental Stage Pending Significant Testing Prior to Certification for Commercial Use
PLAYA VISTA, CA, April 22, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – American Premium Water Corporation (HIPH) announces that it has developed a prototype device that aerosolizes a mixture of the Company’s proprietary Hydro-Nano water and disinfectant agents. This prototype device is currently in the developmental phase; extensive research, environmental, and laboratory testing will be required to be completed before the device and Hydro-Nano water mixture can be commercialized. The Company previously published results in April 2019 on the efficacy of its Hydro Nano technology. The report showed that the synthesis in the Company’s Hydro Nano water reduces the size of the majority of the CBD molecules encapsulated to one nanometer or less in diameter. A full copy of the report can be found here.
The Hydro-Nano water used in the prototype does not contain CBD or any hemp material. The prototype device, which aerosolizes a mixture of Hydro Nano water with disinfecting agents. The Company hypothesizes that the Hydro Nano water will have the same effect on the added sterilizing agents as it does with CBD, shrinking the size of the particles to less than one nanometer in size, which will lead to a more effective sterilizing solution by creating a cloud that will disinfect contact surfaces, and potentially the atmosphere in a room or building. To date, there has not been any testing done by the Company to support or make any claims of sterilization or disinfectant potency about this device or the contents contained in it. A video of the prototype device and its process can be found here.
American Premium CEO Ryan Fishoff commented, “I am pleased to announce the completion of a prototype device that aerosolizes our Hydro Nano water mixed with disinfectants. This is the first step in a long process to develop a usable and scalable product for commercial distribution. Current world events have placed a much greater emphasis on sanitation and sterilization, and the Company believes this device could potentially fulfill that need. The development of this prototype is the first of many steps towards a viable commercial device and formulation; significant laboratory and environmental testing has to be conducted before this device can be sold. But the potential is great; there are many commercial customers that could utilize this technology such as hotels, malls, movie theaters, department stores, boutiques, hospitals, and other retail businesses that would benefit from a quick and effective sanitation solution. I have always felt that the Company’s nanotechnology is a tremendous asset that gets overlooked; there are many potential applications of this technology beyond CBD and hemp. The Company will continue to explore ways to leverage our proprietary nanotech to create shareholder value. I look forward to updating shareholders on our progress in testing, achieving other milestones in the development process of this device, and other avenues that the Company is exploring to monetize existing nanotechnology,” concluded Mr. Fishoff
Vanexxe 2oz can be purchased on Amazon here.
Goldman Research initiated coverage of the Company on February 13th, 2020, giving a $0.0125 price target. To read the full report, click here
About American Premium Water Corp.
American Premium Water (HIPH) is a diversified luxury consumer products company focused on businesses in the health and beauty and biotech sectors. The company is focused on harnessing the powers of Nano technologies paired without cannabidiol (CBD) to treat health disorders and enhance quality of life. The company’s portfolio includes the LALPINA Hydro and LALPINA CBD brands (www.lalpinahydrocbd.com), Gents (www.gentsco.com), Vanexxe (www.vanexxe.com) plant + body essentials (www.plantbodyessentials.com).
Safe Harbor Notice
Certain statements contained herein are “forward-looking statements” (as defined in the Private Securities Litigation Reform Act of 1995). American Premium Water Corporation cautions that statements made in this news release constitute forward-looking statements and makes no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. These statements may address issues that involve significant risks, uncertainties, estimates and assumptions made by management. Actual results could differ materially from current projections or implied results. American Premium Water Corporation undertakes no obligation to revise these statements following the date of this news release. Additional details of the Company's business can be found in its public disclosures as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC" EDGAR database.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Novartis Pulls the Plug on BioArctic Agreement

Updated Category News Views 57

Novartis Drops BioArctic Like a Hot Potato Well, folks, it looks like Novartis has decided to pack up its bags and hightail it out of its collaboration with BioArctic AB. This ain't just any small piece of news—it's got ramifications that have folks in the biotech and healthcare sector scratching their heads and, probably, feeling a mixture of apprehension and...

Continue Reading
NABEP Powers Ahead with Orinoco Furnace Restart

Updated Category News Views 142

Revving Up the Engines in the Orinoco Belt And HERE we are again, ringing the bell on another bold move in the world of energy. NABEP is pulling back the curtain on their revamped activities in the Orinoco Belt. You're telling me they just fired up one heck of a furnace? In this relentless pursuit to spike their output, you've gotta respect the hustle. It's like cranking...

Continue Reading
Differentia Bio's AI: Transforming Drug Development Dynamics

Updated Category News Views 51

The Future of Drug Development: AI's New Role When it comes to pharmaceutical R&D, Some outfits are playing pin the tail on the donkey, but Differentia Bio over here is sharpening the pin with some futuristic gadgetry. Yep, they're jazzing up the game with AI-powered digital twins, building lifelike disease environments that predict therapeutic outcomes with precision...

Continue Reading
Business Formations in 2026: A Blow-by-Blow Analysis

Updated Category News Views 47

Surging Entrepreneurial Spirit in 2026 Just when you’d think economic jitters would slow us down, American entrepreneurship is out there smashing records like a bulldozer through a picket fence. September 2026 saw a staggering 562,579 new business formations—the highest September tally ever logged. That's no fluke. This momentum hasn’t let up all year, and it paints...

Continue Reading
TEKLYNX 2026: Revolutionizing Barcode Labeling Tech

Updated Category News Views 40

In the ever-evolving world of supply chain technology, a big move by TEKLYNX is making waves. The 2026 version of their barcode labeling software isn't just an upgrade—it's a full-blown transformation. They've fine-tuned their suite to align with the latest industry standards and integrated fresh capabilities that scream future-proofing. TEKLYNX's Game-Changing Upgrades...

Continue Reading
Hunan Courts European Investors with Strategic Initiatives

Updated Category News Views 74

Seizing the European Spotlight You've heard of places making a splash, but Hunan smashing through the scene in Europe? Now that's a move you don't see every day. This Chinese province is dead set on stealing the European investment show, with a slick meet-and-greet tour across Germany and Switzerland. What's cooking in Hunan isn't your typical rice porridge—it's a...

Continue Reading
Waters Acquires MOBILion: Ion Mobility Meets AI

Updated Category News Views 18

MOBILion Joins Waters' Fold: A New Era for Proteomics Ah, the biotech world just saw another big whirl with Waters Corporation snagging MOBILion Systems. Now, this isn't just some stroll in the market park. We're talking about weaving MOBILion's fancy high-resolution ion mobility separation tech right into Waters' already robust mass spectrometry setup. These folks are...

Continue Reading
KOVE's Bold Lineup Expansion at EICMA 2026

Updated Category News Views 0

What's Roaring: The Latest from KOVE Anybody who’s been following motorcycle trends knows that EICMA 2026 was destined to be a spectacle, and KOVE didn’t disappoint. They rolled out a fleet of five new models, including the 125 RALLY, 350 RALLY, 650RR, and two head-turners on the electric front: the BONIC and the E-500RR. Each model brings something fresh to the...

Continue Reading
Qapture's Institutional Stablecoin Venture Unveiled

Updated Category News Views 26

Stablecoin Strategy Meets Institutional Investment Here's a fresh one from the digital asset universe. We're talking about Qapture Investments' bold move to launch an institutional-grade stablecoin yield strategy. This ain't your average kitchen table crypto chat—it's the Qapture Safe Haven Vault (QHVN-USD), tailored for those looking to get a better return on their...

Continue Reading
How Octopus AI Reinvents Financial Processes in 2026

Updated Category News Views 56

Stepping into 2026, the buzz in enterprise finance isn’t about a new gadget or slick marketing trick; it's about complex financial processes being tamed by artificial intelligence. Octopus AI is trying to spearhead this transition by automating the intricacies of financial workflows while ensuring that human judgment remains at the helm. The Austin, Texas outfit laid...

Continue Reading

Top 5 Most Recently Viewed Articles

Skyline Medical Faces High Market Pressure with POAI Low at $0.64

Updated Category News Views 93

Skyline Medical Inc. Stock Reaches New Low In the face of a volatile market, Skyline Medical Inc. (POAI) has seen its stock price fall to a concerning 52-week low of $0.64. This sharp decline represents an 81.66% drop over the past year, revealing the significant challenges the company has encountered. Investors are keeping a close watch on POAI's efforts to stabilize...

Continue Reading
Foresight Diagnostics Validates CLARITY MRD Assay for DLBCL

Updated Category News Views 308

Foresight Diagnostics Validates CLARITY MRD Assay for DLBCL Treatment Foresight Diagnostics, a notable player in the diagnostics industry, has shared compelling new findings regarding its CLARITY Minimal Residual Disease (MRD) assay. This groundbreaking information was revealed during a multicenter study focused on frontline Diffuse Large B-Cell Lymphoma (DLBCL). The...

Continue Reading
Surge in Medical Tricorder Demand Drives Market Toward Growth

Updated Category News Views 123

Growing Demand for Medical Tricorders and Future Prospects The medical tricorder market is experiencing significant momentum, with a remarkable valuation of USD 3.7 billion in 2023. This industry is poised for substantial growth, projected to reach USD 6.3 billion by 2032. The compound annual growth rate (CAGR) expected from 2024 to 2032 is approximately 6.1%. The driving...

Continue Reading
Catalis Dental Lab Partners Broadens Reach with New Facility

Updated Category News Views 152

Catalis Dental Lab Partners Expands with New Acquisitions Catalis Dental Lab Partners has reached two significant milestones in its expansion efforts. The company announced the acquisition of Revolution Dental Lab and the launch of a cutting-edge Digital Design Center focused on servicing dental professionals more effectively. Acquisition of Revolution Dental Lab As part...

Continue Reading
Pacific West Bancorp Reports Noteworthy Q2 Financial Achievements

Updated Category News Views 151

Pacific West Bancorp Posts Strong Second Quarter Results Pacific West Bancorp (PWBK), the holding company of Pacific West Bank, recently disclosed its second quarter financial results, revealing a net income of $130 thousand or $0.05 per diluted share. This financial outcome underscores the company's commitment to its growth strategy, as they continue to strengthen their...

Continue Reading